SKELETAL RADIOLOGY《骨胳放射学》(可网站投稿)

SKELETAL RADIOLOGY《骨胳放射学》(月刊). Skeletal Radiology provides a forum for the dissemination of current knowledge and information dealing with disorders of the musculoskeletal system including the spine. While emphasizing the radiological aspects of the many varied skeletal abnormalities, the journal also adopts an interdisciplinary approach, reflecting the membership of the International Skeletal Society. Thus, the anatomical, pathological, physiological, clinical, metabolic and epidemiological aspects of the many entities affecting the skeleton receive appropriate consideration.

杂志简称:skeletal radiol
中文译名:《骨胳放射学》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:18.10%
投稿方向:医学、orthopedics 骨科、radiology, nuclear medicine & medical imaging 核医学

SKELETAL RADIOLOGY《骨胳放射学》

SCI/E期刊基本信息

出版周期:月刊 地区:美国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN 0364-2348;EISSN1432-2161
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:ONE NEW YORK PLAZA,SUITE 4600 ,NEW YORK,United States,NY,10004
杂志邮箱:
投稿网址:https://www.editorialmanager.com/skra/
杂志官方网址:https://www.springer.com/journal/256/
出版商网址:http://www.springeronline.com

杂志投稿要求

期刊邮箱【杂志社官方网站信息】

Editors

Editor-in-Chief

Mark J. Kransdorf

Mayo Clinic

Phoenix, AZ, USA

Phone +1-480-342-0648

Email: kransdorf.mark@mayo.edu

Vice Editors

Thomas M. Link

Department of Radiology and Biomedical Imaging

University of California

San Francisco, CA, USA

Phone +1-415-353-2450

Email: thomas.link@ucsf.edu

William E. Palmer (case reports)

Massachussetts General Hospital

Boston, MA, USA

Phone +1-617-726-7717

Email: wpalmer@mgh.harvard.edu

Contact the journal

Submission-related enquiries

Queries about submission issues, peer review process, or the status of your manuscript should be sent to Mark Compendio (Mark.Compendio@springernature.com).

Publication-related enquiries

Queries about accepted manuscripts in production or post-publication corrections should be sent to Annalyn P. Marabillo (Annalyn.Marabillo@springer.com).

Other editorial enquiries

Any other queries about the journal or presubmission enquiries should be sent to Alexander Santel (alexander.santel@springernature.com).

投稿须知【杂志社官方网站信息】

Skeletal Radiology Instructions for Authors

General Information

All manuscripts should be submitted online at http://www.editorialmanager.com/skra/, following the on-screen instructions.

The Journal does not offer pre-evaluation. Publication decisions are made only after review of the manuscript

Submission requirements for Skeletal Radiology are in accord with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” of the International Committee of Medical Journal Editors (ICMJE). These requirements are available online (http://www.icmje.org).

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institution where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Acceptance of manuscripts for publication is based solely on the Editor’s decision and/or the results of peer review.

All accepted articles will be edited as required to meet the standard of the Journal.

It is the Corresponding Author’s responsibility to ensure that he/she has the correct authors’ names, affiliations, addresses and author sequence when the manuscript is submitted. Changes in authors or in the order of authors will not be accepted after submission of a manuscript.

No corrections are possible after online first publication. In the event of a serious error or omission, if approved by the Editors-in-Chief, a correction will be published and hyperlinked to the original article.

All submissions must be completely blinded for the review process and any identifying information must be removed. This includes any mention of the institutional name or geographic location as well as names or initials of those associated with the study or included in an acknowledgement. The manuscript can be anonymized in Word utilizing the Text Highlight Color tab in the Font menu, by highlighting the text to be anonymized in black, obscuring it.

Ethical Responsibilities of Authors

This Journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the Journal will follow the COPE guidelines (https://publicationethics.org/) on how to deal with potential acts of misconduct.

Authors should include statements concerning conflict of interest, and if applicable, statements on the ethical treatment of human and animal subjects. Statements should be placed in a separate section at the end of the manuscript before the references, entitled “Compliance with Ethical Standards.” Examples are provided in the Conflict of Interest, Ethical Treatment of Human Subjects and Research Involving Animals sections below.

If requested, the corresponding author should be prepared to present evidence of IRB approval.

The Editors reserve the right to reject manuscripts that do not comply with the abovementioned guidelines.

Ethical Principles Regarding Content of the Work

The rules of good scientific practice include:

The manuscript may be submitted to only one journal at a time.

The manuscript has not been published previously (partly or in full). If the manuscript expands upon previous work and/or reused material (or cases), this must be clearly identified and referenced. Failure to do so constitutes “self-plagiarism”.

No data have been fabricated or manipulated (including images).

No data, text, or theories by others are presented as if they were the author’s own (“plagiarism”). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks are used for verbatim copying of material, and permissions are secured for material that is copyrighted.

The Journal routinely uses software to screen for plagiarism.

Upon request authors should be prepared to send documentation or data in order to verify the validity of their results.

Suspicion of Misconduct

If there is a suspicion of misconduct, the Journal will carry out an investigation following the COPE guidelines. If, after investigation, the allegation seems to raise valid concerns, the author will be contacted and given an opportunity to address the issue. If misconduct has been established beyond reasonable doubt, the Editor-in-Chief may implement actions including, but not necessarily limited to, the following:

If the article is still under consideration, it may be rejected and returned to the author.

If the article has already been published online, depending on the nature and severity of the infraction, either a correction will be placed with the article or in severe cases complete retraction of the article will occur. The reason will be published in the erratum or retraction note.

The Department Chair, the Institutional Review Board or Ethics Committee, and/or the hospital administrator/Dean may be notified.

Conflict of Interest

Authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.

Authors must disclose all relationships or interests that could have direct or potential influence or impart bias on the work, even if an author does not think there is any influence on the work being reported.

A conflict of interest is not necessarily inappropriate. Examples of potential conflicts of interest may include but are not limited to the following:

Research grants from funding agencies (please give the research funder and the grant number)

Honoraria for speaking at symposia

Financial support for attending symposia

Financial support for educational programs

Employment or consultation

Support from a project sponsor

Position on advisory board or board of directors or other type of management relationships

Multiple affiliations

Financial relationships, for example equity ownership or investment interest

Intellectual property rights (e.g. patents, copyrights and royalties from such rights)

Holdings of spouse and/or children that may have financial interest in the work

Non-financial interests that may be important to readers should also be disclosed. These may include but are not limited to personal relationships or competing interests directly or indirectly tied to this research, or professional interests or personal beliefs that may influence your research.

The corresponding author collects the conflict of interest disclosure forms from all authors. In author collaborations where formal agreements for representation allow it, it is sufficient for the corresponding author to sign the disclosure form on behalf of all authors.

Some examples of disclosures:

Funding: This study was funded by X (grant number X).

Conflict of Interest:

Author A has no conflict of interest.

Author B has received research grants from Company A;

Author C has received a speaker honorarium from Company X and owns stock in Company Y

If no conflict exists for all, the authors should state:

Conflict of Interest: The authors declare that they have no conflict of interest.

Ethical Treatment of Human Subjects

When reporting studies that involve human participants, authors should include a statement that the studies have been approved by the appropriate institutional and/or national research ethics committee and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This requirement extends to retrospective analyses of patient data as well as prospective studies.

If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach, and demonstrate that the independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study.

The following statements should be included in the text before the References section when reporting studies that involve human participants:

Ethical approval: “All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/38501

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 杂志信息如有错漏 请在下方留言。

上一篇 2025年2月10日 下午9:30
下一篇 2025年2月10日 下午9:35

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息